ZA202209002B - Liquid formulation of gm-csf for inhalation - Google Patents

Liquid formulation of gm-csf for inhalation

Info

Publication number
ZA202209002B
ZA202209002B ZA2022/09002A ZA202209002A ZA202209002B ZA 202209002 B ZA202209002 B ZA 202209002B ZA 2022/09002 A ZA2022/09002 A ZA 2022/09002A ZA 202209002 A ZA202209002 A ZA 202209002A ZA 202209002 B ZA202209002 B ZA 202209002B
Authority
ZA
South Africa
Prior art keywords
csf
inhalation
liquid formulation
rhgm
nebulization
Prior art date
Application number
ZA2022/09002A
Other languages
English (en)
Inventor
Skriver Lars
Watts Alan
Original Assignee
Drugrecure Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugrecure Aps filed Critical Drugrecure Aps
Publication of ZA202209002B publication Critical patent/ZA202209002B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA2022/09002A 2020-03-17 2022-08-11 Liquid formulation of gm-csf for inhalation ZA202209002B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062990810P 2020-03-17 2020-03-17
EP20164648 2020-03-20
PCT/EP2021/056851 WO2021185921A1 (en) 2020-03-17 2021-03-17 Liquid formulation of gm-csf for inhalation

Publications (1)

Publication Number Publication Date
ZA202209002B true ZA202209002B (en) 2025-11-26

Family

ID=74871418

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/09002A ZA202209002B (en) 2020-03-17 2022-08-11 Liquid formulation of gm-csf for inhalation

Country Status (12)

Country Link
US (1) US20230201307A1 (cg-RX-API-DMAC7.html)
EP (1) EP4121000B1 (cg-RX-API-DMAC7.html)
JP (2) JP7631358B2 (cg-RX-API-DMAC7.html)
KR (1) KR102874958B1 (cg-RX-API-DMAC7.html)
CN (1) CN115297844A (cg-RX-API-DMAC7.html)
AU (1) AU2021237761B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022018501A2 (cg-RX-API-DMAC7.html)
CA (1) CA3168421A1 (cg-RX-API-DMAC7.html)
IL (1) IL295406B1 (cg-RX-API-DMAC7.html)
MX (1) MX2022011498A (cg-RX-API-DMAC7.html)
WO (1) WO2021185921A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202209002B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120324338A (zh) * 2025-06-10 2025-07-18 厦门特宝生物工程股份有限公司 一种重组人粒细胞巨噬细胞刺激因子注射用液体制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020141970A1 (en) 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
WO2007009208A1 (en) * 2005-06-02 2007-01-25 Cangene Corporation Poly(ethylene glocol) modified human gm-csf with increased biological activity
CN100394981C (zh) * 2005-09-16 2008-06-18 深圳市孚沃德生物技术有限公司 一种人粒细胞巨噬细胞集落刺激因子喷雾剂及其制备方法
CN1939534B (zh) * 2005-09-27 2010-12-01 长春金赛药业股份有限公司 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
PT2525787T (pt) * 2010-01-19 2017-12-18 Hanmi Science Co Ltd Formulações líquidas para conjugado de g-csf de longa ação
RU2446173C1 (ru) * 2010-08-13 2012-03-27 Зао "Биокад" Новый функционально активный, высокоочищенный стабильный конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем с пролонгированным биологическим действием, пригодный для медицинского применения, и иммунобиологическое средство на его основе
WO2020002650A1 (en) * 2018-06-29 2020-01-02 Targovax Asa A formulation

Also Published As

Publication number Publication date
JP2023517480A (ja) 2023-04-26
BR112022018501A2 (pt) 2022-10-25
WO2021185921A1 (en) 2021-09-23
CN115297844A (zh) 2022-11-04
JP7631358B2 (ja) 2025-02-18
NZ791835A (en) 2025-10-31
KR20220154214A (ko) 2022-11-21
IL295406A (en) 2022-10-01
US20230201307A1 (en) 2023-06-29
EP4121000B1 (en) 2026-07-29
MX2022011498A (es) 2022-10-07
IL295406B1 (en) 2026-06-01
EP4121000A1 (en) 2023-01-25
KR102874958B1 (ko) 2025-10-21
AU2021237761B2 (en) 2026-02-05
CA3168421A1 (en) 2021-09-23
JP2025090573A (ja) 2025-06-17
AU2021237761A1 (en) 2022-09-22

Similar Documents

Publication Publication Date Title
MX2022011498A (es) Formulacion liquida de gm-csf para inhalacion.
TWD208907S (zh) 醫療用通氣管
ZA202208111B (en) Pressurised metered dose inhalers comprising a buffered pharmaceutical formulation
NZ732004A (en) Patient interface for respiratory therapy
NZ630609A (en) Discreet respiratory therapy system
MY162480A (en) Aerosol Inhalator
GB2546949A (en) Substance delivery arrangement for gas therapy device
TWD230485S (zh) 醫療用鼻管總成
EP4684822A3 (en) Nasal devices
CN209809235U (zh) 一种双模块的雾化装置
NZ770002A (en) Nasal mask system
EP4353288A3 (en) Internal cannula mounted nebulizer
PH12014500044A1 (en) Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
TWD210914S (zh) 用於呼吸設備之液體容室
WO2020029469A1 (zh) 一种用于icu根据气流自主呼吸的便携式雾化装置
HK40079244A (en) Liquid formulation of gm-csf for inhalation
CN204972562U (zh) 一种手持式医用雾化器
EM151112570001S (sv) Nebulisatorer för inhalationsbehandling
EM150859720002S (sv) Nebulisatorer för inhalationsbehandling (del av -); Nebulisatorer (del av -)
EM150859720003S (sv) Nebulisatorer för inhalationsbehandling (del av -); Nebulisatorer (del av -)
EM150859720001S (sv) Nebulisatorer för inhalationsbehandling (del av -); Nebulisatorer (del av -)
CN206910565U (zh) 一种中医药雾化器
JP1667208S (ja) 吸入器本体
CN204910396U (zh) 呼吸机专用雾化吸入装置
CN204684430U (zh) 一种呼吸内科给药装置